Stock Quote
CSL Limited (CSL.AX) (Australia Stock Exchange)
$31.00
27 Nov 2009
-1.59%
$31.50
$31.30
2,732,300
$31.60
$30.81
$38.52
$26.85
0.64
1,739,499
CSL.AX
More News
| Press Releases
| Key Developments
| Name | Current Position | Compensation |
|---|---|---|
| Alexander, Elizabeth | Non-Executive Chairman of the Board | 470,000 |
| McNamee, Brian | Chief Executive Officer, Managing Director, Executive Director | 6,074,320 |
| Turner, Peter | President - CSL Behring | 3,152,380 |
Profile
CSL Limited is a biopharmaceutical company engaged in the research, development, manufacture, marketing and distribution of biopharmaceutical and allied products. It operates in three segments: CSL Behring, which is engaged in manufacturing, marketing and developing plasma products; Intellectual... Full Description
Company Address
CSL Limited
45 Poplar Road
Parkville
Victoria VIC 3052
P: +613.93891911
F: +613.93891434
45 Poplar Road
Parkville
Victoria VIC 3052
P: +613.93891911
F: +613.93891434
Analyst Research
| CSL.AX | Industry | |
|---|---|---|
| P/E(TTM) | 16.45 | 12.96 |
| P/S(TTM) | 3.75 | 29.74 |
| ROI(TTM) | 22.92 | 2.44 |
| ROE(TTM) | 27.72 | 3.72 |
| Consensus Recommendation | Outperform |
|---|---|
| EPS Est. (Current Period) | -- |
| EPS Est. (Current Year) | 168.94 |
| Total Revenue | $2,674.53M |
| Net Income | $644.08M |
| EPS | $1.06 |
